Kiwi cervical cancer screening device company TruScreen will try to raise up to $2 million in capital early next year after its unaudited half-year accounts were flagged by directors as a "going concern".
The NZX and ASX-listed company made a $1.22m loss in the six months ending September 30
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
